Donor Lymphocyte Infusion (DLI) Volume
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۳۰۰ • واحد: kg
حداقل ۰.۱ — حداکثر ۱۰۰۰ • واحد: × 10⁶ cells/kg
حداقل ۱ — حداکثر ۱۰ • واحد: infusions
حداقل ۱۰ — حداکثر ۹۰ • واحد: %
حداقل ۱ — حداکثر ۵۰ • واحد: × 10³/μL
حداقل ۵ — حداکثر ۸۰ • واحد: %
حداقل ۳۰ — حداکثر ۹۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low volume0–2000
- Moderate volume2000–5000
- High volume5000–10000
- Very high volume10000–50000
The Donor Lymphocyte Infusion (DLI) Volume calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include recipient weight. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates total blood volume to process by apheresis to produce appropriate DLI dosage
Clinical Indication
The Donor Lymphocyte Infusion (DLI) Volume is indicated for bedside clinical practice to support Estimates total blood volume to process by apheresis to produce appropriate DLI dosage. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies. Guideline pearl: Consider donor safety limits: maximum 12,000 mL processed blood volume recommended.
Total blood volume = (Recipient weight × CD3+ dose × Number of infusions) / (Donor WBC × % Total lymphocytes × % CD3+ lymphocytes × 1000 × Collection efficiency)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| recipient_weight | float | Yes | Recipient weight in kg(kg) |
| cd3_infusion_dose | float | Yes | CD3+ infusion dose (× 10⁶ cells/kg)(× 10⁶ cells/kg) |
| number_of_infusions | integer | Yes | Number of planned infusions(infusions) |
| collection_efficiency | float | Yes | Collection efficiency as percentage (typical: 50%)(%) |
| donor_wbc_count | float | Yes | Donor white blood cell count(× 10³/μL) |
| donor_total_lymphocytes | float | Yes | Donor total lymphocytes as percentage of WBC(%) |
| donor_cd3_lymphocytes | float | Yes | Donor CD3+ lymphocytes as percentage of total lymphocytes(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2000 | Low volume | Small apheresis procedure |
| 2000–5000 | Moderate volume | Standard apheresis procedure |
| 5000–10000 | High volume | Extended apheresis procedure |
| 10000–50000 | Very high volume | Multiple session requirement |
Evidence-Based References (EBM)
- Wingard JR, Hsu J, Hiemenz JW. Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians. 2nd ed. Bethesda, MD: AABB Press; 2010.
- Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood. 1995 Mar 1;85(5):1666-72.
- Kolb HJ, Schattenberg A, Goldman JM, et al. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995 Nov 1;86(5):2041-50.